Open access · OA
via Europe PMC
Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men.
Wakabayashi J, Higashi S, Morifuji M.
Scientific reports · 2026
Abstract
Sublingual administration of nicotinamide mononucleotide (NMN) is hypothesized to enhance systemic bioavailability by bypassing hepatic first-pass metabolism, a significant limitation of oral intake. However, direct comparative evidence in humans has been lacking. This study aimed to compare the acute pharmacokinetics of NMN following single-dose oral and sublingual administration in a randomized, two-period crossover trial involving 14 healthy adult males. Participants received NMN via both routes, separated by an 8-day washout period. Blood samples were collected for 60 min post-administration to measure NMN and its metabolites, including nicotinamide (NAM), nicotinamide adenine dinucleotide (NAD⁺), and the terminal catabolites N1-methyl-2-pyridone-5-carboxamide (2PY) and N1-methyl-4-pyridone-3-carboxamide (4PY). The incremental area under the curve (iAUC) was significantly higher for the terminal metabolites 2PY and 4PY following sublingual administration compared to the oral route. In contrast, no significant differences were found for the blood concentrations of NMN, NAM, or NAD⁺ between methods. Both administration routes were well-tolerated, with no adverse events reported. These findings provide the first direct evidence in humans that sublingual administration leads to a more rapid increase in the terminal metabolites (2PY and 4PY) over 0-60 min, although the metabolic origin of these increases could not be distinguished in the present study.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1038/s41598-026-57552-9
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
J, W., S, H., & M., M. (2026). Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men. <em>Scientific reports</em>. https://doi.org/10.1038/s41598-026-57552-9
Vancouver
J W, S H, M. M. Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men. Scientific reports. 2026. doi:10.1038/s41598-026-57552-9.
BibTeX
@article{wakabayashi2026Sublin,
title = {Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men.},
author = {Wakabayashi J and Higashi S and Morifuji M.},
journal = {Scientific reports},
year = {2026},
doi = {10.1038/s41598-026-57552-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Scientific Reports 2023
Open access · CC-BY
Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
Endocrine Journal 2024
Open access · CC-BY
Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men
Research Square 2021
Preprint · CC-BY
Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle motility in healthy old men
Frontiers in Nutrition 2022
Open access · CC-BY
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects
Expert Opinion on Pharmacotherapy 2021
Preprint · OA
Development of the PARP inhibitor talazoparib for the treatment of advanced<i>BRCA1</i>and<i>BRCA2</i>mutated breast cancer
Endocrine Journal 2019
Open access · OA